The neurotensin receptor 1 agonist PD 149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model
Neurogastroenterology & Motility · 2024
DOI: 10.1111/nmo.14925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2024. Verfasst von Tsukasa Nozu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regional Medicine and Education, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Receptors, Neurotensin, Rats, Sprague-Dawley, Colon. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Akiyama Life Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
An impaired intestinal barrier with the activation of corticotropin‐releasing factor (CRF), Toll‐like receptor 4 (TLR4), and proinflammatory cytokine signaling, resulting in visceral hypersensitivity, is a crucial aspect of irritable bowel syndrome (IBS). The gut exhibits abundant expression of neurotensin; however, its role in the pathophysiology of IBS remains uncertain. This study aimed to clarify the effects of PD149163, a specific agonist for neurotensin receptor 1 (NTR1), on visceral sensation and gut barrier in rat IBS models.
Methods
The visceral pain threshold in response to colonic balloon distention was electrophysiologically determined by monitoring abdominal muscle contractions, while colonic permeability was measured by quantifying absorbed Evans blue in colonic tissue in vivo in adult male Sprague–Dawley rats. We employed the rat IBS models, i.e., lipopolysaccharide (LPS)‐ and CRF‐induced visceral hypersensitivity and colonic hyperpermeability, and explored the effects of PD149163. Key Results Intraperitoneal PD149163 (160, 240, 320 μg kg −1 ) prevented LPS (1 mg kg −1 , subcutaneously)‐induced visceral hypersensitivity and colonic hyperpermeability dose‐dependently. It also prevented the gastrointestinal changes induced by CRF (50 μg kg −1 , intraperitoneally). Peripheral atropine, bicuculline (a GABA A receptor antagonist), sulpiride (a dopamine D 2 receptor antagonist), astressin 2 ‐B (a CRF receptor subtype 2 [CRF 2 ] antagonist), and intracisternal SB‐334867 (an orexin 1 receptor antagonist) reversed these effects of PD149163 in the LPS model. Conclusions and Inferences PD149163 demonstrated an improvement in visceral hypersensitivity and colonic hyperpermeability in rat IBS models through the dopamine D 2 , GABA A , orexin, CRF 2 , and cholinergic pathways. Activation of NTR1 may modulate these gastrointestinal changes, helping to alleviate IBS symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Regional Medicine and Education, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Center for Medical Education, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Department of General Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Division of Neuroscience, Department of Physiology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
ORCID-Profile: Tsukasa Nozu, Toshikatsu Okumura
Förderung
- Akiyama Life Science Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Nozu, T., Miyagishi, S., Ishioh, M., Takakusaki, K., & Okumura, T. (2024). The neurotensin receptor 1 agonist PD 149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14925
Vancouver
Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. The neurotensin receptor 1 agonist PD 149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14925
BibTeX
@article{Nozu2024,
author = {Nozu, Tsukasa and Miyagishi, Saori and Ishioh, Masatomo and Takakusaki, Kaoru and Okumura, Toshikatsu},
title = {The neurotensin receptor 1 agonist PD 149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model},
journal = {Neurogastroenterology & Motility},
year = {2024},
doi = {10.1111/nmo.14925}
}
EUVIMED